My perspective article in Microbiology is now published as part of the @microbiologysociety.org Emerging Investigator Collection: a manufacturing-focused look at the opportunities and challenges for CFPS. www.microbiologyresearch.org/content/jour...

Microbial cell-free protein synthesis and its progression toward industrial use

Industrial adoption of microbial cell-free protein synthesis (CFPS), an in vitro protein production platform that uses transcription and translation machinery from lysed cells, remains limited despite...

microbiologyresearch.org

Bursaries available for #Pichia2026! We have a limited number of bursaries for ECRs who need support to attend the conference. Available to new registrants and those who have already registered. Deadline is 25 Feb — apply soon! 👉 tinyurl.com/Pichia2026bu...

It’s the last day to submit your abstracts and register for early bird registration. Join us in Mallorca for #Pichia2026 👉 Register here: lnkd.in/eQ8ruK8E 👉 Submit your abstract here: lnkd.in/etYt-bUk

This November, I’m joining the University of Nottingham as Assistant Professor in Microbiology to launch my lab. We’ll explore Pichia pastoris, cell-free protein synthesis, and in vitro glycosylation to create flexible, efficient protein production platforms.

Proud to share our pre-print describing our cell-free two step approach for the production of conjugate vaccines. Not only do we produce vaccines at scale in 5 days, but show an immunogenic response in mice.

bioRxiv Synthetic Biology@biorxiv-synthbio.bsky.social · last yr.

A scalable cell-free manufacturing platform for two-step bioproduction of immunogenic conjugate vaccines https://www.biorxiv.org/content/10.1101/2025.08.05.668792v1

We're excited to announce the next Pichia conference in Mallorca Spain in March 2026. Save the date, and join our LinkedIn page (lnkd.in/dzztWMPD) or subscribe on our website (www.pichia2026.com) to receive updates.

Thrilled to share our efforts in showcasing the manufacturing capabilities of cell-free gene expression for biotherapeutics. analyticalsciencejournals.onlinelibrary.wiley.com/doi/10.1002/...

Scalable Cell‐Free Production of Active T7 RNA Polymerase

The SARS-CoV-2 pandemic highlighted the urgent need for biomanufacturing paradigms that are robust and fast. Here, we demonstrate the rapid process development and scalable cell-free production of T7...

analyticalsciencejournals.onlinelibrary.wiley.com

I’m so happy that the major focus of my PhD is out! Very proud of what we accomplished here, and excited for the potential this tech has to enhance future point-of-care protein diagnostics. www.science.org/doi/10.1126/...

A modular cell-free protein biosensor platform using split T7 RNA polymerase

A split polymerase is used to develop a plug-and-play cell-free biosensor platform for point-of-care protein detection.

science.org